Clinical data and evaluation of that clinical data is an explicitly defined legal requirement for medical devices. Solutions to fast-track market access may emerge from wearables and data analytics programs and allow a stronger and more efficient patient engagement and monitoring. What impact and scalability do these IT solutions have on the medical device clinical trial design? How are they integrated in the market access strategies of MedTech players?
How do IT tools contribute to accelerate the process of completing clinical trials in the MedTech sector?
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 4:00 PM
- 5:30 PM
- Aly Talen, Co-Founder & Sr. VP Business Development, GENAE
- Elie Lobel, CEO, ORANGE HEALTHCARE
- Silvia Casellas, ANAGRAM, Director of Clinical Research and CEO
- Barbara D’Haene, CEO, AKCELIS
- Christophe Amiel, Senior director, Medical devices & combination products, VOISIN CONSULTING LIFE SCIENCES
